Form EFFECT Syros Pharmaceuticals,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 11, 2025 |
| Accession Number: | 0001193125-25-050873 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tron Coin Price Holds at $0.32 as Pepeto Presale Crosses $10.2M While TRX Lands OKX Europe Listing
- Polygon Price Prediction Shifts After Mastercard Deal as Pepeto Presale Crosses $10.2M Before Listing
- BlockDAG’s $0.05 Buyback Strategy Makes It One of the Top Crypto Gainers Over Solana & Pi Network
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
